Head Neck
-
Publication Venue For
- Factors associated with employment discontinuation among older and working age survivors of oropharyngeal cancer.. 41:3948-3959. 2019
- Prognostic value of radiographically defined extranodal extension in human papillomavirus-associated locally advanced oropharyngeal carcinoma.. 41:3056-3063. 2019
- Salvage laryngectomy and laryngopharyngectomy: Multicenter review of outcomes associated with a reconstructive approach.. 41:16-29. 2019
- Salvage skull base reconstruction in the endoscopic era: Vastus lateralis free tissue transfer.. 40:E45-E52. 2018
- ACR appropriateness criteria® nasal cavity and paranasal sinus cancers.. 39:407-418. 2017
- Prognostic value of midtreatment FDG-PET in oropharyngeal cancer.. 38:1472-1478. 2016
- ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.. 38:1299-1309. 2016
- ACR Appropriateness criteria® for nasopharyngeal carcinoma.. 38:979-986. 2016
- ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck.. 38:175-182. 2016
- Clinicopathologic factors and adjuvant treatment effects on survival in adult head and neck synovial cell sarcoma.. 37:375-380. 2015
- Primary granulocytic sarcoma of larynx.. 37:E38-E44. 2015
- Comparison of complications in free flap reconstruction for osteoradionecrosis in patients with or without hyperbaric oxygen therapy.. 36:1701-1704. 2014
- Esophageal-subarachnoid fistula: a case of spontaneous tension pneumocephalus in the setting of esophageal cancer.. 36:E52-E56. 2014
- Surgical innovation, industry partnership, and the enemy within.. 36:461-465. 2014
- Incidence and risk factors of significant carotid artery stenosis in asymptomatic survivors of head and neck cancer after radiotherapy.. 36:215-219. 2014
- American College of Radiology Appropriateness Criteria(®) treatment of stage I T1 glottic cancer.. 36:3-8. 2014
- Health-related quality of life differences between African Americans and non-Hispanic whites with head and neck cancer.. 35:1255-1264. 2013
- Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers.. 35:794-799. 2013
- Reply, contralateral irradiation for T(limited)N2bM0 lateralized tonsil cancer.. 35:465-466. 2013
- Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia.. 34:1681-1703. 2012
- Chemoradiation for patients with large-volume laryngeal cancers.. 34:1162-1167. 2012
- Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia.. 34:1136-1142. 2012
- Treatment-induced changes in vocal cord mobility and subsequent local recurrence after organ preservation therapy for laryngeal carcinoma.. 34:792-796. 2012
- ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil.. 34:613-616. 2012
- Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites.. 33:847-855. 2011
- Association between a functional polymorphism (-1195T>C) in the IGFBP5 promoter and head and neck cancer risk.. 33:650-660. 2011
- Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue.. 32:1519-1527. 2010
- Immunotherapy using allogeneic squamous cell tumor-dendritic cell fusion hybrids.. 32:1209-1216. 2010
- Toll-like receptor agonists as third signals for dendritic cell-tumor fusion vaccines.. 32:700-707. 2010
- Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma.. 32:348-356. 2010
- Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer.. 31:195-201. 2009
- Trends in head and neck cancer incidence in Tianjin, China, between 1981 and 2002.. 31:175-182. 2009
- Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.. 30:1535-1542. 2008